TY - JOUR
T1 - NIHSS 24 h After Mechanical Thrombectomy Predicts 90-Day Functional Outcome
AU - Hendrix, Philipp
AU - Melamed, Itay
AU - Collins, Malie
AU - Lieberman, Noah
AU - Sharma, Vaibhav
AU - Goren, Oded
AU - Zand, Ramin
AU - Schirmer, Clemens M.
AU - Griessenauer, Christoph J.
N1 - Funding Information:
The authors P. Hendrix, I. Melamed, M. Collins, N. Lieberman, V. Sharma, O. Goren, R. Zand, C.M. Schirmer and C.J. Griessenauer have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Outside the presented work: OG received consulting fees from Stryker; CMS received research funding from Penumbra and has ownership in NTI; CG received research funding from Medtronic and Penumbra, and consulting fees from Stryker and MicroVention.
Publisher Copyright:
© 2021, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/6
Y1 - 2022/6
N2 - Background: Mechanical thrombectomy (MT) for large vessel occlusion (LVO) ischemic stroke is a safe and effective treatment modality. The National Institute of Health Stroke Scale (NIHSS) 24 h after MT (24 h-NIHSS) was shown to serve as the strongest surrogate for 90-day functional outcome. Here, we seek to externally validate 24 h-NIHSS as predictor for 90-day functional outcome and explore additional variables in this context. Methods: Patients treated for anterior LVO between February 2016 and August 2020 with premorbid mRS < 3 were included. Receiver operating characteristics were used to compare different NIHSS-related surrogates, such as baseline (B) NIHSS, 24 h-NIHSS, Δ‑NIHSS and percent (%) change NIHSS to predict favorable function outcome (mRS 0–2). Additional analysis was performed to assess predictors associated with poor outcome despite reaching the best predictor threshold. Results: A total of 337 eligible cases were identified. The 24 h-NIHSS outperformed B‑NIHSS, Δ‑NIHSS, and %‑NIHSS in terms of 90-day mRS 0–2 prediction. A 24-NIHSS ≤ 8 was identified as the optimal binary threshold. Multivariable analysis demonstrated that 24-NIHSS ≤ 8 and younger patient age were independently associated with mRS 0–2. Despite achieving 24 h-NIHSS ≤ 8, 23/143 (16.1%) cases experienced poor outcome (mRS 4–6). Older age, higher baseline NIHSS, coexisting chronic kidney disease, and longer hospital stay were independent predictors for poor outcome despite achieving 24 h-NIHSS ≤ 8. Conclusion: An NIHSS of 8 or less 24 h after MT was validated to serve as an independent, strong surrogate for favorable functional outcome; however, cofactors such as older age, higher baseline NIHSS and coexisting comorbidities appear to mitigate this clinical adjunct.
AB - Background: Mechanical thrombectomy (MT) for large vessel occlusion (LVO) ischemic stroke is a safe and effective treatment modality. The National Institute of Health Stroke Scale (NIHSS) 24 h after MT (24 h-NIHSS) was shown to serve as the strongest surrogate for 90-day functional outcome. Here, we seek to externally validate 24 h-NIHSS as predictor for 90-day functional outcome and explore additional variables in this context. Methods: Patients treated for anterior LVO between February 2016 and August 2020 with premorbid mRS < 3 were included. Receiver operating characteristics were used to compare different NIHSS-related surrogates, such as baseline (B) NIHSS, 24 h-NIHSS, Δ‑NIHSS and percent (%) change NIHSS to predict favorable function outcome (mRS 0–2). Additional analysis was performed to assess predictors associated with poor outcome despite reaching the best predictor threshold. Results: A total of 337 eligible cases were identified. The 24 h-NIHSS outperformed B‑NIHSS, Δ‑NIHSS, and %‑NIHSS in terms of 90-day mRS 0–2 prediction. A 24-NIHSS ≤ 8 was identified as the optimal binary threshold. Multivariable analysis demonstrated that 24-NIHSS ≤ 8 and younger patient age were independently associated with mRS 0–2. Despite achieving 24 h-NIHSS ≤ 8, 23/143 (16.1%) cases experienced poor outcome (mRS 4–6). Older age, higher baseline NIHSS, coexisting chronic kidney disease, and longer hospital stay were independent predictors for poor outcome despite achieving 24 h-NIHSS ≤ 8. Conclusion: An NIHSS of 8 or less 24 h after MT was validated to serve as an independent, strong surrogate for favorable functional outcome; however, cofactors such as older age, higher baseline NIHSS and coexisting comorbidities appear to mitigate this clinical adjunct.
UR - http://www.scopus.com/inward/record.url?scp=85112772709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112772709&partnerID=8YFLogxK
U2 - 10.1007/s00062-021-01068-4
DO - 10.1007/s00062-021-01068-4
M3 - Article
C2 - 34402916
AN - SCOPUS:85112772709
SN - 1869-1439
VL - 32
SP - 401
EP - 406
JO - Clinical Neuroradiology
JF - Clinical Neuroradiology
IS - 2
ER -